It is these PRM‐based strategies in particular that have most recently advanced our understanding and interpretation of tau truncation and metabolism in AD both in vivo and in vitro (Barthélemy et al. 2016, 2019, 2020; Sato et al. 2018). Here, MAPT is linked to Alzheimer disease.